Literature DB >> 31515605

Feasibility of adopting retroperitoneal robotic partial nephrectomy after extensive transperitoneal experience.

Ronney Abaza1, Robert S Gerhard1, Oscar Martinez2.   

Abstract

PURPOSE: Adoption of robotic retroperitoneal surgery has lagged behind robotic surgery adoption in general due to unique challenges of access and anatomy. We evaluated our initial results with robotic retroperitoneal robotic partial nephrectomy (RRPN) after transitioning from exclusively transperitoneal robotic partial nephrectomy (TRPN) to evaluate safety and any identifiable learning curve.
METHODS: We evaluated our single-surgeon (RA) prospective partial nephrectomy database since adopting RRPN routinely for posterior tumors in 2017. The surgeon had previously performed 410 partial nephrectomies by this time. Outcomes were compared after the initial 30 RRPN.
RESULTS: Of 137 patients since adopting RRPN, two attempted RRPN were converted to TRPN without complications due to morbid obesity affecting access, and 30 RRPN were completed (107 TRPN). There were no statistically significant differences in demographics, mean tumor size, or RENAL score between groups. Mean blood loss was lower in RRPN (53 mL vs 99 mL, P < 0.05), but there were no transfusions in either group. There was no difference in mean operative (127.8 min vs 141.2 min, P = 0.06) or ischemia time (11.1 min vs 10.8 min, P = 0.98). There were no positive margins in either group. Mean length of stay was lower in RRPN due to more same-day discharges (0.7 vs 0.9 days). There were no 90-day Clavien III-V complications. One RRPN patient was readmitted POD#8 overnight for hypoxia, and one visited the emergency room POD#7 for persistent pain. All three TRPN complications were managed as outpatients.
CONCLUSIONS: Successful adoption of RRPN can be achieved readily after experience with TRPN. Outcomes were immediately comparable without any identifiable learning curve.

Entities:  

Keywords:  Kidney tumors; Partial nephrectomy; Retroperitoneal approach; Robotic surgery

Mesh:

Year:  2019        PMID: 31515605     DOI: 10.1007/s00345-019-02935-z

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  5 in total

1.  Retroperitoneal versus transepritoneal robot-assisted partial nephrectomy for postero-lateral renal masses: an international multicenter analysis.

Authors:  Umberto Carbonara; Daniel Eun; Ithaar Derweesh; Umberto Capitanio; Antonio Celia; Cristian Fiori; Enrico Checcucci; Daniele Amparore; Jennifer Lee; Alessandro Larcher; Devin Patel; Margaret Meagher; Fabio Crocerossa; Alessandro Veccia; Lance J Hampton; Francesco Montorsi; Francesco Porpiglia; Riccardo Autorino
Journal:  World J Urol       Date:  2021-05-29       Impact factor: 4.226

2.  Comparison of Outcomes Between Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy: A Meta-Analysis Based on Comparative Studies.

Authors:  Daqing Zhu; Xue Shao; Gang Guo; Nandong Zhang; Taoping Shi; Yi Wang; Liangyou Gu
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

3.  Comparison of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Patients With Complete Upper Pole Renal Tumors.

Authors:  Liangyou Gu; Wenlei Zhao; Junnan Xu; Baojun Wang; Qiang Cheng; Donglai Shen; Yundong Xuan; Xupeng Zhao; Hongzhao Li; Xin Ma; Xu Zhang
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

Review 4.  Retroperitoneal Robot-assisted Partial Nephrectomy: A Systematic Review and Pooled Analysis of Comparative Outcomes.

Authors:  Umberto Carbonara; Fabio Crocerossa; Riccardo Campi; Alessandro Veccia; Giovanni E Cacciamani; Daniele Amparore; Enrico Checcucci; Davide Loizzo; Angela Pecoraro; Michele Marchioni; Chiara Lonati; Chandru P Sundaram; Reza Mehrazin; James Porter; Jihad H Kaouk; Francesco Porpiglia; Pasquale Ditonno; Riccardo Autorino
Journal:  Eur Urol Open Sci       Date:  2022-04-26

5.  Novel Gerota-edge-sling technique facilitates retroperitoneal robot-assisted partial nephrectomy: a comparative study.

Authors:  Wei Chen; Qixiang Fang; Haomin Ren; Lei Ma; Jin Zeng; Shangshu Ding; Dapeng Wu
Journal:  BMC Urol       Date:  2022-08-20       Impact factor: 2.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.